Felicia Adelina Stanford is investigating the pathogenic properties of fungi in the SFB/TR FungiNet. Image: Anna Schroll/Leibniz-HKI
Felicia Adelina Stanford is investigating the pathogenic properties of fungi in the SFB/TR FungiNet. Image: Anna Schroll/Leibniz-HKI - Collaborative Research Center granted DFG funding for a further four years. Life The German Research Foundation (DFG) will fund the Collaborative Research Center/Transregio (CRC/TR) "FungiNet" for four more years with approximately ten million Euro. In the only CRC studying human pathogenic fungi, scientists in Jena and Würzburg will investigate infection processes and novel therapeutic options. Fungal infections are a major challenge for modern medicine. Elderly or immunocompromised patients, for example those with leukemia or requiring organ transplantation, are particularly at risk. These life-threatening infections are often diagnosed too late, treatment options are extremely limited, and the pathogens are increasingly resistant to available drugs.
UM DIESEN ARTIKEL ZU LESEN, ERSTELLEN SIE IHR KONTO
Und verlängern Sie Ihre Lektüre, kostenlos und unverbindlich.